2024-12-28 08:43:26
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5
Health/ 2023-07-22
I-Mab Biopharma Receives IND Approval in...

SHANGHAI,Oct. 4,2019-- I-Mab Biopharma ("I-Mab"),a China and U.S.-based clinical stage biopharmaceutical company exclusively focus...

Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million
Corporate/ 2023-07-23
Innovent Biologics Announces a New Place...

SUZHOU,China,Oct. 4,2019--Innovent Biologics,Inc. ("Innovent" or "the Company") (HKEX: 01801),a world-class biopharmaceu...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release